15469-97-3

Basic information

• Product Name: 1-(Triphenylmethyl)imidazole
• Synonyms: N-TRITYLIMIDAZOLE;(TRIPHENYLMETHYL)IMIDAZOLE;1-(TRIPHENYLMETHYL)IMIDAZOLE;1-TRITYL-1H-IMIDAZOLE;1-TRITYLIMIDAZOLE;N-(Triphenylmethyl)imidazole;CDD 3501;ClotriMazole IMpurity F
• CAS NO: 15469-97-3
• Molecular Formula: C₂₂H₁₈N₂
• Molecular Weight: 310.39
• EINECS: -0
• Product Categories: blocks;Imidazoles;Building Blocks;Heterocyclic Building Blocks;Building Blocks;Chemical Synthesis;Heterocyclic Building Blocks;Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 15469-97-3.mol
• Article Data: 24

Chemical Properties

• Melting Point: 220-224 °C(lit.)
• Boiling Point: 451.294 °C at 760 mmHg
• Flash Point: 226.734 °C
• Appearance: /
• Density: 1.058 g/cm³
• Vapor Pressure: 6.57E-08mmHg at 25°C
• Refractive Index: 1.606
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: DMSO (Slightly, Sonicated), Methanol (Slightly, Sonicated)
• PKA: 6.34±0.30(Predicted)
• Water Solubility: Insoluble in water.
• BRN: 238171
• CAS DataBase Reference: 1-(Triphenylmethyl)imidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Triphenylmethyl)imidazole(15469-97-3)
• EPA Substance Registry System: 1-(Triphenylmethyl)imidazole(15469-97-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 15469-97-3(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 15469-97-3 differently. You can refer to the following data:
1. 1-Tritylimidazole is a Clotrimazole (C587400) analog as antifungal agent.
2. 1-(Triphenylmethyl)imidazole may be used in the synthesis of 1,2,5-trisubstituted imidazole derivatives.

General Description

1-(Triphenylmethyl)imidazole is an imidazole derivative.

InChI:InChI=1/C22H18N2/c1-4-10-19(11-5-1)22(24-17-16-23-18-24,20-12-6-2-7-13-20)21-14-8-3-9-15-21/h1-18H

Upstream product

• 288-32-4 1H-imidazole 
• 596-43-0 bromo-triphenyl-methane 
• 1252858-34-6 4-amino-5-iodo-7-[2,3,5-tris-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidine 
• 96797-15-8 N-trityl-4⁽⁵⁾-iodoimidazole 
• 76-84-6 triphenylmethyl alcohol 
• 102-10-3 diphenyl phosphite 
• 119-61-9 benzophenone 
• 108-86-1 bromobenzene 
• 87268-78-8 2-trityl-5-phenyl-2H-tetrazole 
• 76-83-5 trityl chloride 
• 68-12-2 N,N-dimethyl-formamide 
• 28697-53-2 D-arabinopyranose 
• 3473-63-0 formamidine acetic acid 
• 95953-45-0 triphenylmethyl 4-cyanophenyl ether 

Downstream Products

• 191542-49-1 2-tosyl-1-(triphenylmethyl)-1H-imidazole 
• 873215-54-4 4-hydroxy-4-(1-trityl-1H-imidazol-2-yl)-piperidine-1-carboxylic acid ethyl ester 
• 37594-47-1 1-(4,4',4''-trichloro-trityl)-1H-imidazole 
• 102210-86-6 2-Carbomethoxy-1-tritylimidazole 
• 288-32-4 1H-imidazole 
• 223420-00-6 (+/-)-trans-4-(2-(4-cyclopentylbut-1-ynyl)cyclopropyl)imidazole 
• 223420-02-8 (+/-)trans-4-(2-(4-cyclohexylbut-1-ynyl)cyclopropyl)imidazole 
• 203655-46-3 (10-Methoxymethyl-10H-pyrazino[2,3-b][1,4]benzothiazin-8-yl)-[1-(triphenylmethyl)imidazol-2-yl]methanol 
• 23593-68-2 2-methyl-1-tritylimidazole 
• 121816-83-9 4-bromo-2-methyl-1-tritylimidazole 

Relevant articles and documents

HETEROCYCLIC COMPOUND

Provided is a compound that can have an effect of inhibiting MALT1 and is expected as useful as a prophylactic or therapeutic drug for cancer, etc. A compound represented by formula (I) [wherein each symbol is as defined in the description], a salt thereo

A process for preparing 7-bromo imidazo [2,1-f] [1, 2, 4] triazin-4-amine method

The invention discloses a method for preparing 7-bromoimidazo[2,1-f][1,2,4]triazin-4-amine. According to the invention, a compound IX is adopted as a a raw material, and is subjected to a reaction with a compound X under the effect of alkali, such that a

First selective CYP11B1 inhibitors for the treatment of cortisol-dependent diseases

Outgoing from an etomidate-based design concept, we succeeded in the development of a series of highly active and selective inhibitors of CYP11B1, the key enzyme of cortisol biosynthesis, as potential drugs for the treatment of Cushing's syndrome and rela